Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Buy
2,754
+359
+15% +$35.6K ﹤0.01% 1468
2026
Q1
$225K Buy
2,395
+323
+16% +$32.2K ﹤0.01% 1337
2025
Q4
$205K Buy
+2,072
New +$200K ﹤0.01% 1285
2025
Q1
Sell
-52,792
Closed -$3.65M 1254
2024
Q4
$3.65M Buy
52,792
+39,749
+305% +$2.83M 0.03% 289
2024
Q3
$862K Buy
13,043
+390
+3% +$24.9K 0.01% 695
2024
Q2
$767K Sell
12,653
-22,760
-64% -$1.29M 0.01% 668
2024
Q1
$2.02M Buy
+35,413
New +$2.13M 0.02% 352

Other funds holding INCY

Savant Capital's INCY Position: Q2 2026 in Review

Savant Capital increased its Incyte (INCY) stake by 15% in Q2 2026, buying an estimated $35.6K and bringing the position to 2,754 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.

Savant Capital first reported a position in INCY in Q1 2024 and has held it in 7 quarters since. The position peaked at $3.65M in Q4 2024. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Savant Capital held 2,754 shares of Incyte worth $316K as of Q2 2026.
  • Savant Capital bought 359 Incyte shares in Q2 2026, an estimated $35.6K.
  • Incyte made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1468 holding.
  • Savant Capital first reported a position in Incyte in Q1 2024 and has held it in 7 quarters since.
  • Savant Capital's Incyte position peaked at $3.65M in Q4 2024.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.